A carregar...
Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus
BACKGROUND: The apolipoprotein B/A1 (apoB/A1) ratio is a stronger predictor of future cardiovascular disease than is the level of conventional lipids. Statin and ezetimibe combination therapy have shown additional cardioprotective effects over statin monotherapy. METHODS: This was a single-center, r...
Na minha lista:
| Publicado no: | Diabetes Metab J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Diabetes Association
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6834829/ https://ncbi.nlm.nih.gov/pubmed/30688048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0124 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|